CHARLES ALAN STEVENS
Pharmacy in Lansdale, PA
License number
Pennsylvania RP034407R
Category
Pharmacy
Type
Pharmacist
Address
Address
Lansdale, PA 19446
Personal information
See more information about CHARLES ALAN STEVENS at radaris.comName
Address
Phone
547 Dock Dr, Lansdale, PA 19446
Professional information
Simethicone Containing Pharmaceutical Compositions
US Patent:
5599577, Feb 4, 1997
Filed:
May 31, 1995
Appl. No.:
8/455427
Inventors:
Charles A. Stevens - Lansdale PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Assignee:
McNeil-PPC, Inc. - Skillman NJ
International Classification:
B05D 312, A61K 924, A61J 300
US Classification:
427 214
Abstract:
A method of making solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier. The barrier is formed by coating with a polymer impermeable to simethicone.
Simethicone Containing Pharmaceutical Compositions
US Patent:
5679376, Oct 21, 1997
Filed:
May 31, 1995
Appl. No.:
8/455443
Inventors:
Charles A. Stevens - Lansdale PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Assignee:
McNeil-PPC, Inc. - Skillman NJ
International Classification:
A61K 924, A61K 926, A61K 952
US Classification:
424472
Abstract:
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone.
Simethicone Containing Pharmaceutical Compositions
US Patent:
5716641, Feb 10, 1998
Filed:
Mar 20, 1996
Appl. No.:
8/619116
Inventors:
Charles A. Stevens - Lansdale PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Assignee:
McNeil-PPC, Inc. - Skillman NJ
International Classification:
A61K 958, A61K 962, A61K 924, A61K 926
US Classification:
424472
Abstract:
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone.
Simethicone Containing Pharmaceutical Compositions
US Patent:
5980944, Nov 9, 1999
Filed:
Nov 25, 1997
Appl. No.:
8/978358
Inventors:
Charles A. Stevens - Lansdale PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Michael R. Hoy - North Wales PA
Edward J. Roche - Paoli PA
Assignee:
McNeil-PPC, Inc. - Skillman NJ
International Classification:
A61K 926, A61K 952, A61K 31765
US Classification:
424470
Abstract:
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of granules of diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier coat on the granules which is substantially impermeable to simethicone.